ArticleMetabolites2014

Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide.

Miroslava Cuperlovic-Culf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.